How Companies Can Avoid ‘Patent Cliff’ With Revolutionary Trilexon® Delivery System

NEW YORK, April 28, 2014 /PRNewswire/ — Harvey Tauman, CEO of Greyson International, Inc. (otc pink sheets: GYSN) is back in stride as he takes his Trilexon® message directly to Wall Street on www.Wall-Street.com with the same robust style that made him one of QVC’s most prolific presenters, setting $100 million sales records.

Tauman’s video presentation debuts today on Wall-Street.com in which he explains how the Trilexon Delivery System can save pharmaceutical products from cascading off “the patent cliff.” Wall-Street.com recognizes exceptional microcap companies and is a premier financial center for information.

“I want Wall Street to know what we have here,” says Tauman enthusiastically, explaining how Trilexon can extend patent life by adding the revolutionary transdermal delivery system to products.

Tauman’s message is fresh on the heels of his announcement last week that one of the leading interactive multi-channel retailers in North America, The Shopping Channel of Canada (tsc.ca), will offer for sale Greyson’s innovative new skin care line containing its patented transdermal delivery system Trilexon (www.greysonintl.com).  “We now have a way for pharmaceutical and anti-aging ingredients to be released in the skin for extended periods for maximum effectiveness.

Greyson line includes Perfect Balance Moisturizer, which minimizes fine lines and wrinkles, lifts skin and strengthens the barrier layer on skin by keeping pH at 4.5-5. In this pH range barrier layer repairs itself and the skin readily accepts the active ingredients. Also a Clean Complex Foaming Cleanser and Pore Diminishing Toner, providing foundation of a cleanser and toner engineered to clean without stripping the essential oils from our skin, balances the pH to prepare the skin to readily accept the moisturizing ingredients.

About Greyson International, Inc. Trilexon® is a registered trademark of Greyson International Inc. http://greysonintl.com. Facebook page:http://www.facebook.com/GreysonInternationalInc .
This release contains information about management’s view of future expectations, plans and prospects that constitute forward-looking statements for purposes of safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements resulting from a variety of factors including, but not limited to, risks and uncertainties associated with Greyson’s financial condition, its ability to sell products or compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contacts: Greyson International Inc., Harvey Tauman, 954-482-0497,Chief Executive Officer, Harvey@greysonintl.com

Media contact: Abigail Blake 561-750-9800 x2290; abby@transmediagroup.com.

SOURCE Greyson International, Inc.

With Start Of Sales Of Anti-Aging Skin Care At www.greysonintl.com, Greyson International, Inc. (OTC Pink Sheets: GYSN) CEO Keeps A Promise To A Cosmetics Titan

COCONUT CREEK, Fla., July 8, 2014 /PRNewswire/ — With the fulfillment of orders this week at (www.greysonintl.com) for the Greyson Skin Care Three-Piece Kit with the revolutionary Trilexon® topical delivery system, Harvey Tauman keeps a promise he made to cosmetics industry titan, the late Charlie Fox.

Fox was the inventive chemist who developed the unique delivery system, which Tauman, CEO of Greyson International, Inc. (OTC Pink Sheets: GYSN) calls “the smart phone of the cosmetics industry.”

Tauman promised Fox, one of Warner-Lamberts’ most prolific product developers, that his dream for Trilexon® helping people worldwide would come true.

Greyson owns and secured a patent on these products containing Trilexon®, which are selling on www.greysonintl.com after years of development.

“Trilexon® will help people rejuvenate their skin like never before,” said Tauman who was founder and CEO of Hydron Technologies, Inc. when its stock on NASDAQ surged from 37 1/2 cents to $14.75, making it the biggest percentage gainer in 1983.

In April 1994, Tauman was chief spokesman of cosmetic and personal care products on QVC shopping channel, where he broke sales records, including $2.1M in one day of Hydron’s products.

The Greyson’s three-piece Skincare Kit with Trilexon® on sale for $99 contains a Perfect Balance Moisturizer, Clean Complex Foaming Cleanser and Pore Diminishing Toner each with Trilexon®, which releases pharmaceutical and anti-aging ingredients on the skin over extended periods. This technology supports the skins barrier layer which maintains a specific pH level on the skin and reduced moisture evaporation, thus promoting the ingredient penetration. Also, Trilexon’s® extended delivery of ingredients into the skin lasts longer.

In independent third party laboratory tests, performed by Peter T. Pugliese, M.D. and Zoe Diana Draelos, M.D., Trilexon® proved to deliver active ingredients at a consistent rate for extended periods. Unlike most emulsion systems which continue to emulsify once applied on the skin and breaks down the barrier layer, the Greyson’s Trilexon® Delivery System stops emulsifying the essential oils and keeps the barrier layer intact.

“Trilexon® is the single most important development in cosmetics in the past 50 years,” said Tauman.

About Greyson International, Inc. Trilexon® is a registered trademark of Greyson International, Inc. http://greysonintl.com. Facebook page:http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of future expectations, plans and prospects that constitute forward-looking statements for purposes of safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements resulting from a variety of factors including, but not limited to, risks and uncertainties associated with Greyson’s financial condition, its ability to sell products or compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission

Contacts: Greyson International, Inc., Harvey Tauman, 954-482-0497,Chief Executive Officer, Harvey@greysonintl.com, Media contact: Adrienne Mazzone 561-750-9800 x2270; amazzone@transmediagroup.com

Greyson International, Inc. Announces the Untimely Death of Its Chairman and CEO

COCONUT CREEK, Fla., July 29, 2014 /PRNewswire/ — Greyson International Inc. (OTC Pink: GYSN), developer of an innovative, patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that Harvey Tauman, the Company’s Chairman and CEO, passed away this morning unexpectedly. Mr. Tauman was 73 years old. He had been hospitalized recently for treatment of respiratory failure.

The Board of Directors issued the following statement: “We are greatly saddened by the passing of Harvey Tauman.  The Company’s directors and employees, as well as the many people he worked with over the years, mourn his loss.  We extend our sympathies to his family.”

C. Mukesh Prasad, the Company’s Director and Vice-President will preside as Chairman and CEO over the interim period.

Chaudhury Mukesh Prasad, Vice President 
Mr. Prasad has served as the Vice President of Operations for Greyson International, Inc. since 2003. He is now serving on the Board of Directors of the Company as well as Corporate Secretary and Executive Vice President. Previously employed for 25 years at Hydron Technologies, Inc., Mr. Prasad held the positions of Controller, Vice President, Corp. Secretary, and member of the board as well as other various operational roles.

Mr. Prasad brings significant hands on managerial experience to Greyson International, Inc.  He assists the Company with product development, production and launch of various skin care and hair care products.  He has extensive experience in business operations, accounting, purchasing, manufacturing, warehousing, fulfillment center, and human resources.  Mr. Prasad studied Physics, Chemistry and Math at collage in India and studied accounting, and management in USA.  He is also an active member of the Society of Cosmetic Chemist.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact
Greyson International Inc.
C. Mukesh Prasad, 954-482-0497
Interim Chief Executive Officer

Greyson International, Inc. (OTC Pink Sheets: GYSN) Announced Oct. 17 Canadian Kickoff on The Shopping Channel of Its Anti-Aging Skin Care.  Greyson says it’s a Clear Sign Company’s Moving Vigorously Forward after Death of Its Legendary CEO as He Had Wanted

COCONUT CREEK, Fla., September 30, 2014. — Greyson International, Inc. (OTC Pink Sheets: GYSN announced today the long-awaited TV launch of the Greyson Skin Care product line, with the patented Trilexon® topical delivery system, will be Oct. 17. It will receive four separate thirty (30) minute live TV airings that day on one of the leading interactive multi-channel retailers in North America, The Shopping Channel of Canada (tsc.ca), just as the company’s late CEO Harvey Tauman had planned prior to his death in July.

The well-known TV spokesperson Andrea Tilis will present the Greyson Skin Care kit on Oct. 17 at 9:30am, 1:30pm, 4:30pm and 8:30pm on The Shopping Channel seen throughout Canada. (All times are Eastern.)

“We’re excited to be carrying out the first of many things my father had planned to do as he believed so passionately.  Our skin care products with Trilexon are infinitely more effective and longer lasting than any other cosmetics,” said his son, Richard Tauman, Director of Operations of the company, now headed by Mukesh Prasad.  The company was founded by Harvey Tauman, who had held some of the most awesome cosmetics sales records in the history of TV home shopping.

Our technology supports the skins barrier layer and maintains a specific pH level on the skin to reduce moisture evaporation, thus promoting the ingredient penetration. Also, Trilexon’s® extended delivery of ingredients into the skin lasts longer.

In independent third party laboratory tests, performed by Peter T. Pugliese, M.D. and Zoe Diana Draelos, M.D., Trilexon® proved to deliver active ingredients at a consistent rate for extended periods. Unlike most emulsion systems once applied on the skin, it continues to emulsify and break down the barrier layer, the Greyson’s Trilexon® Delivery System stops emulsifying the essential oils and keeps the barrier layer intact.

About Greyson International, Inc.

Greyson’s patented Trilexon® delivery system, in addition to cosmetic applications, may have benefits in the medical field where it’s important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International Inc. Information is available http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with company’s financial condition, ability to sell its products and compete with competitors.  Please review other factors that may affect our future results on any current or future documents we file periodically with Securities & Exchange Commission.

Contacts:

Greyson International, Inc., Mukesh Prasad 954-482-0497, President, mukesh@greysonintl.com.

Media: Adrienne Mazzone 561-750-9800 x2270; amazzone@transmediagroup.com.

Coconut Creek, Fla. – February 28, 2013 – Greyson International Inc. (OTC Pink: GYSN), developer of an innovative, patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced an update on its passive investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered oil and gas company with properties located in the country of Georgia.

“Greyson has been advised that the joint venture between Blake and the MND Group has been funded and new seismic data is being collected across all three properties. A drilling campaign is expected to commence later this year and continue through 2014.” said Greyson International Inc. CEO Harvey Tauman.

On March 12, 2012, Greyson acquired a private entity that resulted in a 3% passive ownership stake in Blake. On August 14, 2012, Blake entered into a joint venture agreement with MND Group whereby the latter received a 50% interest in Blake’s Georgian assets in exchange for assuming exploration and production costs. Under the terms of the agreement, the MND Group committed to over $100 million in capital expenditures to fund the development of the Ninotsminda, Manavi and Norio assets.

According to an independent report issued by Netherland, Sewell & Associates Inc. and Oilfield Production Consultants, these properties could have significant oil and gas reserves. More information about these assets can be found on Blake’s website, www.blakeoilandgas.com.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

COCONUT CREEK, Fla. – April 10, 2013 — Greyson International Inc. (OTC Pink: GYSN), developer of an innovative, patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that Greyson is forming a subsidiary that will have a business plan which will target the multi-billion dollar pharmaceutical industry.

“Greyson’s management team has been diligently working to launch our new Greyson Biomedical subsidiary and commercialize Trilexon® Delivery System in potentially enormous medical end markets,” said Greyson International Inc. CEO Harvey Tauman. “After demonstrating efficacy in topical applications in OTC products, our goal is to license our patented technology to companies interested in improving efficacy of their existing products   or creating altogether new products.

Greyson International’s patented Trilexon® technology (U.S. Patent 8,268,335) combines a cationic emulsifying agent, oil soluble liquid polymer and naturally occurring lactate buffer system to dramatically improve the topical delivery of active ingredients. Unlike normal delivery agents, the patented formulation effectively delivers active ingredients to the skin at a more desirable pH level to enhance delivery/efficacy.

“We believe there is a lot of potential for Trilexon® Delivery System within the biomedical industry,” added CEO Harvey Tauman. “With more durable and stable delivery of active ingredients, we see potential in prescription products that promote healing, restore damaged cells, and relieve topical pain, as well as topical OTC products like pain relievers, eczema treatment, anti-itch creams, burn relief products, or sunscreens etc. Our team is working diligently to prove these claims and launching the new subsidiary in the near future in order to generate significant long-term value for our shareholders.”

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact

Greyson International Inc.
Harvey Tauman, 954-482-0497
Chief Executive Officer
Harvey@greysonintl.com

Greyson International Provides an Update on its Operations

COCONUT CREEK, Fla.–(June 10, 2013)–Greyson International Inc. (OTC Pink: GYSN), developer of an innovative, patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced the sale of a portion of its interest in Blake Oil & Gas Limited (“Blake”), a privately owned, Guernsey registered oil and Gas Company with operations in the country of Georgia. The proceeds of approximately $1 million will be used to aggressively pursue retail distribution deals for its breakthrough Trilexon® powered products, as well as market Greyson Bio medical’s technology to potential licensees in the pharmaceutical industry.

Covered by U.S. Patent 8,268,335, Greyson International’s Trilexon® technology combines a cationic emulsifying agent, oil soluble liquid polymer and natural occurring lactate buffer system to dramatically improve the topical delivery of active ingredients in both the cosmetics and pharmaceutical industries.

“The sale of a portion of our interest in Blake provides us with the funding necessary to unlock the enormous potential in our breakthrough Trilexon® delivery technology across multiple end markets,” said Greyson International Inc. CEO Harvey Tauman. “We believe that Trilexon® will play a vital role in both the hypercompetitive cosmetics industry, where companies are always looking for a competitive edge, and the pharmaceutical industry where the larger players are facing so-called patent cliffs, and are looking for new ways to extend patent lives.”

Management will provide additional details about these programs as they are implemented over the coming months.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International Inc. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Greyson International Inc.
Harvey Tauman, 954-482-0497
Chief Executive Officer
Harvey@greysonintl.com

COCONUT CREEK, Fla. – July 22, 2013- Greyson International Inc. (OTC Pink Sheets: GYSN), developer of an innovative patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that talks with patent law firm Lerner Greenberg Stemer LLP resulted in across the board agreement with Greyson’s plan to help save and stave the potential $90+ billion loss in the pharmaceutical market.

Large pharmaceutical companies are facing a so-called “patent cliff”, whereby brand names drugs, once having delivered steady sales and profits are losing, or have already lost, their patent protection.  Johnson and Johnson (NYSE:JNJ) has had three blockbuster drug patents expire in the last two years, Eli Lilly’s (NYSE:LLY) Cymbalta loses its patent at the end of 2013, and Pfizer (NYSE:PFE) recently attained a short extension on multibillion-dollar Celebrex which expires in Dec. 2015.

Lerner Greenberg Stemer LLP patent law firm for the world’s largest multinational corporations concur with Greyson’s plan to utilize their patented Trilexon® trans-dermal topical delivery system in several ways. “Leveraging our technology, large pharmaceutical companies can potentially reformulate their drugs to be delivered topically instead of orally, extend patent lives, and/or create new patents quickly under the Greyson umbrella” said Harvey Tauman, CEO of Greyson International Inc. “Greyson International, in addition to being debt free, has invested millions over a period of about 20 years culminating to the point whereby preparation is meeting opportunity.”

Currently Greyson International has anchored a large manufacturer, added two prominent physicians as consultants, and recruited top industry beauty consultants for Greyson Skincare® with Trilexon® technology.  Their new spokesperson and brand manager, Tia Castle is preparing to launch Greyson Skincare line on network shopping television toward the fourth quarter of 2013.  Greyson is open to adding new talent to the managerial team as it rapidly expands to meet market demands.  All inquiries may contact Harvey Tauman.

Greyson International’s revolutionary patented Trilexon® delivery system allows the finest ingredients to be released topically over an extended period of time, while maintaining the skin’s natural intracellular barrier to promote natural moisture and lipid levels, providing a comfortable and durable experience that’s unlike anything else in the market.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International Inc. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com